Post-Market Review of Pharmaceutical Benefits Scheme Medicines to Treat Asthma in Children

12 February 2013

The Pharmaceutical Benefits Advisory Committee has agreed to consider a report on the Post-Market Review of Pharmaceutical Benefits Scheme Medicines to Treat Asthma in Children. The Department is now inviting submissions addressing the Terms of Reference to this Review. Further information, including the Terms of Reference for the Review, is available at: Post-Market Review of Pharmaceutical Benefits Scheme Medicines to Treat Asthma in Children.